Jing Xu

5.6k citations
152 papers · 4.0k indexed · 1 hit paper · h-index 34
Topics
Lung Cancer Treatments and Mutations (8 papers)Endoplasmic Reticulum Stress and Disease (6 papers)COVID-19 Clinical Research Studies (6 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Jing Xu

135 papers receiving 3.9k citations

Hit Papers

Plasma phospho‐tau181 increases with Alzheimer's disease ...20182026202020232018100200300400

Peers

Jing Xu
Comparison fields: 5 of 164
  • Molecular Biology 1.7k
  • Physiology 626
  • Oncology 535
  • Cell Biology 436
  • Immunology 410
Replace Fuu‐Jen Tsai with:
Fuu‐Jen Tsai Taiwan
Julio Sotelo Mexico
Ertan Mayatepek Germany
Fen Wang China
Wei‐Chiao Chang Taiwan
Nicola Brunetti‐Pierri Italy
Alvin C. Powers United States
Ying Liu China
Uwe Lendeckel Germany
Mark D. Johnson United States
Jing Xu relative to Fuu‐Jen Tsai Taiwan Fuu‐Jen Tsai's profile →
Citations per field
00.5×
Fuu‐Jen Tsai · 1×
Citations per year

Countries citing papers authored by Jing Xu

Since Specialization
Citations

This map shows the geographic impact of Jing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Xu more than expected).

Fields of papers citing papers by Jing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Xu. The network helps show where Jing Xu may publish in the future.

Co-authorship network of co-authors of Jing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Xu. A scholar is included among the top collaborators of Jing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Xu. Jing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 3
5 2
6 7
7 0
8 1
9 1
10 22
11 1
12 1
13 33
14 3
15 3
16 80
17 9
18 68
19 78
20 19

About Jing Xu

Jing Xu is a scholar working on Oncology, Genetics and General Energy, having authored 152 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Cell Biology (436 citations), Cancer Research (373 citations) and Molecular Biology (1.7k citations). Jing Xu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Jun O. Liu, Yongjun Dang, Zhibiao Wang, Yunzhao R. Ren, Chenglai Fu, Solomon H. Snyder, Curtis R. Chong, Luis F. Parada, Feng Rao and Shridhar Bhat. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026